Published in Mov Disord on January 01, 1998
Ethanol Response in Essential Tremor: Clinical and Neurophysiological Correlates | NCT01200966
Prevalence of essential tremor in a multiethnic, community-based study in northern Manhattan, New York, N.Y. Neuroepidemiology (2009) 2.28
Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor. Neurotoxicology (2007) 1.98
Elevation of blood beta-carboline alkaloids in essential tremor. Neurology (2002) 1.88
A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology (2005) 1.63
Essential tremors: a family of neurodegenerative disorders? Arch Neurol (2009) 1.49
Clinical characteristics of essential tremor in Mersin, Turkey--a population-based door-to-door study. J Neurol (2005) 1.33
Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J Clin Invest (2005) 1.22
Wireless fast-scan cyclic voltammetry to monitor adenosine in patients with essential tremor during deep brain stimulation. Mayo Clin Proc (2012) 1.21
Environmental epidemiology of essential tremor. Neuroepidemiology (2008) 1.11
Association between essential tremor and blood lead concentration. Environ Health Perspect (2003) 1.11
Essential tremor prevalence is low in Arabic villages in Israel: door-to-door neurological examinations. J Neurol (2006) 1.09
Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC Neurol (2010) 1.05
Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats. J Toxicol Environ Health A (2001) 1.05
The management of tremor. J Neurol Neurosurg Psychiatry (2002) 1.02
Improved spatial targeting with directionally segmented deep brain stimulation leads for treating essential tremor. J Neural Eng (2012) 1.01
From neurons to neuron neighborhoods: the rewiring of the cerebellar cortex in essential tremor. Cerebellum (2014) 0.99
Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol (2012) 0.99
Functional Brain Activity Relates to 0-3 and 3-8 Hz Force Oscillations in Essential Tremor. Cereb Cortex (2014) 0.98
Essential tremor, the cerebellum, and motor timing: towards integrating them into one complex entity. Tremor Other Hyperkinet Mov (N Y) (2012) 0.97
Philadelphia Geriatric Morale Scale in essential tremor: a population-based study in three Spanish communities. Mov Disord (2008) 0.96
The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry (2005) 0.94
Slowed saccades and increased square wave jerks in essential tremor. Tremor Other Hyperkinet Mov (N Y) (2013) 0.93
Population-based prospective study of cigarette smoking and risk of incident essential tremor. Neurology (2008) 0.92
Essential tremor might be less frequent than Parkinson's disease in North Israel Arab villages. Mov Disord (2009) 0.92
Neuroimaging of Essential Tremor: What is the Evidence for Cerebellar Involvement? Tremor Other Hyperkinet Mov (N Y) (2012) 0.92
Development of an essential tremor embarrassment assessment. Parkinsonism Relat Disord (2010) 0.91
Population-based study of baseline ethanol consumption and risk of incident essential tremor. J Neurol Neurosurg Psychiatry (2009) 0.91
Deep brain stimulation for movement disorders. Neurotherapeutics (2014) 0.89
Current clinical application of deep-brain stimulation for essential tremor. Neuropsychiatr Dis Treat (2013) 0.89
Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New York. J Toxicol Environ Health A (2012) 0.88
Intracranial applications of magnetic resonance-guided focused ultrasound. Neurotherapeutics (2014) 0.87
Balance confidence and falls in nondemented essential tremor patients: the role of cognition. Arch Phys Med Rehabil (2014) 0.86
Overview of essential tremor. Neuropsychiatr Dis Treat (2010) 0.85
Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremor. Neurotoxicology (2008) 0.82
Tractography-Based Ventral Intermediate Nucleus Targeting: Novel Methodology and Intraoperative Validation. Mov Disord (2016) 0.81
A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice. Hippokratia (2010) 0.80
Thalamic physiology of intentional essential tremor is more like cerebellar tremor than postural essential tremor. Brain Res (2013) 0.80
LINGO-1 and Neurodegeneration: Pathophysiologic Clues for Essential Tremor. Tremor Other Hyperkinet Mov (N Y) (2012) 0.80
Haplotype analysis of the ETM2 locus in familial essential tremor. Neurogenetics (2003) 0.79
Essential Tremor Prevalence is Low in the Druze Population in Northern Israel. Tremor Other Hyperkinet Mov (N Y) (2012) 0.78
Effects of DBS on precision grip abnormalities in essential tremor. Exp Brain Res (2009) 0.78
Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey. BMJ Open (2015) 0.77
Prevalence of essential tremor in urban Lagos, Nigeria: a door-to-door community-based study. BMC Neurol (2012) 0.77
Sensorineural Hearing Loss in Non-depressed Essential Tremor Cases and Controls: A Clinical and Audiometric Study. Tremor Other Hyperkinet Mov (N Y) (2015) 0.77
Dystonia and Tremor: The Clinical Syndromes with Isolated Tremor. Tremor Other Hyperkinet Mov (N Y) (2016) 0.76
Essential tremor. BMJ Clin Evid (2007) 0.76
Bilateral cerebellar activation in unilaterally challenged essential tremor. Neuroimage Clin (2015) 0.76
Dose-escalation study of octanoic acid in patients with essential tremor. J Clin Invest (2016) 0.76
Parkinsonism and tremor disorders. A clinical approach. Libyan J Med (2007) 0.75
Essential tremor. BMJ Clin Evid (2015) 0.75
Outcome of gamma knife thalamotomy in patients with an intractable tremor. J Korean Neurosurg Soc (2015) 0.75
Rest tremor revisited: Parkinson's disease and other disorders. Transl Neurodegener (2017) 0.75
Immediate and Longitudinal Alterations of Functional Networks after Thalamotomy in Essential Tremor. Front Neurol (2016) 0.75
A Network Model of Local Field Potential Activity in Essential Tremor and the Impact of Deep Brain Stimulation. PLoS Comput Biol (2017) 0.75
Topiramate Treatment of Essential Tremor in a Patient with Cognitive Deficits. Case Rep Neurol (2010) 0.75
Memory Similarities Between Essential Tremor and Parkinson's Disease: A Final Common Pathway? Clin Neuropsychol (2015) 0.75
Public Knowledge and Attitude toward Essential Tremor: A Questionnaire Survey. Front Neurol (2016) 0.75
Quantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of doneness. J Toxicol Environ Health A (2007) 0.75
Intention Tremor of the Legs in Essential Tremor: Prevalence and Clinical Correlates. Mov Disord Clin Pract (2015) 0.75
Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat. Br J Pharmacol (2016) 0.75
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol (1998) 5.54
Parkinson disease in twins: an etiologic study. JAMA (1999) 5.45
Remission of seizures and relapse in patients with epilepsy. Epilepsia (1979) 4.17
Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke (2001) 4.07
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology (1995) 3.91
The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia (1975) 3.67
Comparative safety of antiepileptic drugs during pregnancy. Neurology (2012) 3.32
Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med (1987) 3.21
A population-based study of seizures after traumatic brain injuries. N Engl J Med (1998) 3.12
Recent developments in molecular epidemiology: A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol (1998) 2.96
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96
Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet (1995) 2.72
Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke (1998) 2.70
A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology (1996) 2.69
The protective effect of moderate alcohol consumption on ischemic stroke. JAMA (1999) 2.68
Long-term mortality after a first episode of status epilepticus. Neurology (2002) 2.60
Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology (2004) 2.59
The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol (1993) 2.48
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology (2007) 2.41
Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med (1995) 2.33
The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology (2005) 2.32
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology (2006) 2.25
Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet (1994) 2.24
Seizure recurrence after a first unprovoked seizure. N Engl J Med (1982) 2.23
Premorbid weight, body mass, and varsity athletics in ALS. Neurology (2002) 2.23
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2008) 2.22
Cysticercosis and epilepsy: a critical review. Epilepsia (1998) 2.21
Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology (2001) 2.19
Hypertension and the risk of new-onset unprovoked seizures. Neurology (1993) 2.19
Accuracy of family history data on Parkinson's disease. Neurology (2003) 2.15
Smoking and Parkinson's disease in twins. Neurology (2002) 2.15
Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology (2011) 2.06
Major depression is a risk factor for seizures in older adults. Ann Neurol (2000) 2.05
Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke (1997) 2.00
A prospective study of recurrent febrile seizures. N Engl J Med (1992) 1.99
Semistructured interview for seizure classification: agreement with physicians' diagnoses. Epilepsia (1990) 1.93
Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol (1995) 1.85
Higher risk of seizures in offspring of mothers than of fathers with epilepsy. Am J Hum Genet (1988) 1.84
Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst (1994) 1.72
Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology (1998) 1.72
Reliability of seizure classification using a semistructured interview. Neurology (1993) 1.71
Driving and epilepsy. A review and reappraisal. JAMA (1991) 1.69
LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology (2004) 1.67
Predictors of disease course in patients with probable Alzheimer's disease. Neurology (1987) 1.66
Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol (1984) 1.65
The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics (1996) 1.65
Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol (1994) 1.63
The risk of epilepsy following febrile convulsions. Neurology (1979) 1.61
Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology (1992) 1.61
Classification of partial seizure symptoms in genetic studies of the epilepsies. Neurology (2006) 1.59
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology (2010) 1.57
Mortality in patients with epilepsy. Epilepsia (1980) 1.56
Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol (2000) 1.56
Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. Arch Neurol (2000) 1.55
Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol (2001) 1.55
Epidemiology of epilepsy. Adv Neurol (1978) 1.54
Seizures and myoclonus in patients with Alzheimer's disease. Neurology (1986) 1.53
Population-based study of seizure disorders after cerebral infarction. Neurology (1996) 1.52
Familial clustering of seizure types within the idiopathic generalized epilepsies. Neurology (2005) 1.51
Specificity of the fivefold increase in AD in mothers of adults with Down syndrome. Neurology (2001) 1.50
Short-term mortality after a first episode of status epilepticus. Epilepsia (1997) 1.49
Relations of genetic and environmental factors in the etiology of epilepsy. Ann Neurol (1996) 1.47
Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol (1998) 1.46
Familial breast cancer in a population-based series. Am J Epidemiol (1986) 1.44
Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology (2000) 1.44
Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol (1993) 1.42
Incidence and prognosis of Bell's palsy in the population of Rochester, Minnesota. Mayo Clin Proc (1971) 1.42
Risk factors for a first febrile seizure: a matched case-control study. Epilepsia (1995) 1.40
Dementia and adult-onset unprovoked seizures. Neurology (1996) 1.37
Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia (1995) 1.37
Identification of epilepsy genes in human and mouse. Annu Rev Genet (2001) 1.32
Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology (2001) 1.31
Risk of recurrence after an initial unprovoked seizure. Epilepsia (1986) 1.31
Validity of telephone interview data for vascular disease risk factors in a racially mixed urban community: the Northern Manhattan Stroke Study. Neuroepidemiology (1999) 1.29
Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc (1996) 1.28
Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia (1998) 1.28
Practical guide for estimating risk for familial breast cancer. Lancet (1983) 1.26
Familial aggregation of Paget's disease of bone. J Bone Miner Res (1991) 1.26
Clinical indicators of genetic susceptibility to epilepsy. Epilepsia (1996) 1.23
Predictors of recurrent febrile seizures: a metaanalytic review. J Pediatr (1990) 1.21
Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology (1994) 1.20
Psychologic and social adjustment to epilepsy in Rochester, Minnesota. Neurology (1989) 1.20
Relationship between ambient air pollution and DNA damage in Polish mothers and newborns. Environ Health Perspect (1998) 1.20
Severe, uncontrolled hypertension and adult-onset seizures: a case-control study in Rochester, Minnesota. Epilepsia (1996) 1.20
Are generalized and localization-related epilepsies genetically distinct? Arch Neurol (1998) 1.20
Frequency and clinical determinants of dementia after ischemic stroke. Neurology (2000) 1.19
Epidemiology and the genetics of epilepsy. Res Publ Assoc Res Nerv Ment Dis (1983) 1.19
Alcohol consumption and withdrawal in new-onset seizures. N Engl J Med (1988) 1.19
Familial risk of migraine: a population-based study. Ann Neurol (1997) 1.18
Validity of family history data on seizure disorders. Epilepsia (1993) 1.18
Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics (1990) 1.17